IBI-Ag is a manufacturer of bio-insecticides using antibody technology for crop protection. The company has developed natural single domain antibody insecticides to increase crop production, based on naturally-derived proteins with minimal impact on people, plants, and crops. The bio-insecticides are suitable for use against any type of insect pest, offering a sustainable alternative to traditional chemical pesticides. Founded in 2017 and headquartered in Ness Ziona, Israel, IBI-Ag has raised approximately 10 million at the Series A stage with investors including The Trendlines Group, Bayer, Corteva Agriscience, Iron Nation, Consensus Business Group, Innovation Israel, First Imagine, and Bandera.
← All startups
IBI-Ag
Series AIBI-Ag is a manufacturer of bio-insecticides using antibody technology for crop protection. The company has developed natural single domain antibody insecticides to increase crop production, based on naturally-derived proteins with minimal impact on people, plants, and crops. The bio-insecticides are suitable for use against any type of insect pest, offering a sustainable alternative to traditional chemical…
About
Business model
Crop Tech > Farm Inputs > Biologicals > Crop Protection > Plant Based,
Chemicals Tech > Green Chemicals > Crop Protection > Plant Based
Institutional investors
The Trendlines GroupBayerCorteva AgriscienceIron NationConsensus Business GroupInnovation IsraelFirst ImagineBandera
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.